Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Irritable Bowel Syndrome I: Introduction01:17

Irritable Bowel Syndrome I: Introduction

1.4K
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
1.4K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation01:30

Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation

1.0K
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
1.0K
Chronic Bowel Disorders: Introduction01:17

Chronic Bowel Disorders: Introduction

896
Chronic bowel diseases are a group of long-term conditions affecting the digestive tract, characterized by inflammation and damage to the gut lining. These conditions primarily include irritable bowel syndrome and inflammatory bowel disease.
Irritable Bowel Syndrome (IBS) is a common disorder affecting the gastrointestinal tract. The distinctive feature is recurrent abdominal pain associated with altered bowel movements, manifesting as constipation, diarrhea, or fluctuating between both. The...
896
Irritable Bowel Syndrome III: Medical and Nursing Management01:30

Irritable Bowel Syndrome III: Medical and Nursing Management

963
Managing Irritable Bowel Syndrome (IBS) involves a multifaceted approach, including lifestyle modifications, dietary changes, and medication.
963
Drugs for Treatment of Diarrhea-Predominant IBS01:17

Drugs for Treatment of Diarrhea-Predominant IBS

854
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
854
Gastrointestinal Motility Disorders01:20

Gastrointestinal Motility Disorders

1.5K
Gastrointestinal or GI motility disorders are characterized by irregular gastrointestinal tract movements, disrupting food transit from the mouth to the anus. They are caused by damage or dysfunction in gut muscles or nerves. These disorders can cause symptoms such as severe constipation, diarrhea, abdominal pain, and swallowing difficulties. Disorders can affect any segment of the GI tract and range widely in severity, from common conditions like GERD to life-threatening conditions like...
1.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Impact of Cholecystectomy on Gastric Mucosal c-MYC and h-TERT Expression; A Potential Link to Gastric Cancer Development.

Balkan journal of medical genetics : BJMG·2026
Same author

Superior vena cava syndrome as a manifestation of primary atypical carcinoid tumor of mediastinum by [68Ga]Ga-DOTA-TATE PET/CT.

Revista espanola de medicina nuclear e imagen molecular·2026
Same author

Fecal microbiota transplantation as an early therapeutic option in treatment refractory Clostridioides difficile infection.

Journal of gastroenterology and hepatology·2024
Same author

Systemic inflammation response index is associated MACE in patients with NSTEMI.

European review for medical and pharmacological sciences·2023
Same author

The course of Autoimmune Thyroiditis in WOMEN.

Acta endocrinologica (Bucharest, Romania : 2005)·2022
Same author

Association of CABG SYNTAX score with long term clinical outcomes in patients with acute myocardial infarction undergoing SVG PCI.

European review for medical and pharmacological sciences·2022

Related Experiment Video

Updated: Mar 22, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
10:37

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

8.7K

Is there any association between irritable bowel syndrome subgroups and autonomous dysfunction.

A E Yildirim1, M Korkmaz, R Altun

  • 1Department of Gastroenterology, Department of Internal Medicine, Başkent University, Faculty of Medicine, Ankara, Turkey. yildirimemrea@yahoo.com.

European Review for Medical and Pharmacological Sciences
|April 22, 2016
PubMed
Summary

Autonomic dysfunction (AD) plays a role in irritable bowel syndrome (IBS) pathophysiology. IBS patients, particularly those with IBS-C, show more pronounced AD compared to healthy controls, suggesting a link to disease severity.

More Related Videos

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
07:41

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice

Published on: February 3, 2016

14.9K
In vitro Functional Characterization of Mouse Colorectal Afferent Endings
14:09

In vitro Functional Characterization of Mouse Colorectal Afferent Endings

Published on: January 21, 2015

10.3K

Related Experiment Videos

Last Updated: Mar 22, 2026

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform
10:37

Perturbations of Circulating miRNAs in Irritable Bowel Syndrome Detected Using a Multiplexed High-throughput Gene Expression Platform

Published on: November 30, 2016

8.7K
Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice
07:41

Video Imaging and Spatiotemporal Maps to Analyze Gastrointestinal Motility in Mice

Published on: February 3, 2016

14.9K
In vitro Functional Characterization of Mouse Colorectal Afferent Endings
14:09

In vitro Functional Characterization of Mouse Colorectal Afferent Endings

Published on: January 21, 2015

10.3K

Area of Science:

  • Gastroenterology
  • Neurology
  • Internal Medicine

Background:

  • Irritable bowel syndrome (IBS) is a prevalent functional gastrointestinal disorder.
  • The brain-gut axis is crucial in IBS, but the role of autonomic dysfunction (AD) remains debated.
  • Understanding AD's contribution to IBS pathophysiology is essential for improved management.

Purpose of the Study:

  • To investigate and compare autonomic dysfunction in different irritable bowel syndrome subgroups.
  • To assess the relationship between autonomic dysfunction and IBS characteristics.

Main Methods:

  • Included 50 IBS patients and 49 healthy controls.
  • Evaluated autonomic function using parasympathetic and sympathetic tests.
  • Categorized patients into IBS subgroups (IBS-C, IBS-D).

Main Results:

  • No demographic differences between IBS patients and controls.
  • Significant differences in parasympathetic and sympathetic autonomic neuropathy tests were observed.
  • IBS-C patients exhibited more severe parasympathetic dysfunction compared to IBS-D patients and controls.
  • No correlation found between autonomic dysfunction severity and disease duration.

Conclusions:

  • Autonomic dysfunction is implicated in the pathophysiology of irritable bowel syndrome.
  • Deterioration of the autonomic system in IBS may affect multiple organ systems, including the cardiovascular system.
  • Patients with IBS may face a broader range of health complications due to autonomic system impairment.